Showing results (151-160 of 588) with videos related to

Sort By:
Pageof 59
Melanoma Research|May 30, 2009
Nuclear PTEN levels and G2 progression in melanoma cellsAbraham I Jacob, Todd Romigh, Kristin A Waite, et al.
BMC Bioinformatics|March 16, 2019
Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma riskVisanu Wanchai, Jing Jin, Emine Bircan, et al.
Cell Reports. Medicine|January 19, 2024
Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndromeDarren Liu, Lamis Yehia, Andrew Dhawan, et al.
Endocrine-Related Cancer|December 14, 2017
The microbiome in PTEN hamartoma tumor syndromeVictoria Byrd, Ted Getz, Roshan Padmanabhan, et al.
Translational Psychiatry|January 22, 2019
Constitutional mislocalization of Pten drives precocious maturation in oligodendrocytes and aberrant myelination in model of autism spectrum disorderHyunpil Lee, Stetson Thacker, Nicholas Sarn, et al.
Human Molecular Genetics|October 8, 2010
Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53Xin He, Ying Ni, Yu Wang, et al.
Annales D'Endocrinologie|December 6, 2020
Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectivesVincent Amodru, Marie-Eve Garcia, Rossella Libe, et al.
Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.
Journal of Personalized Medicine|January 8, 2015
Formative evaluation of clinician experience with integrating family history-based clinical decision support into clinical practiceMegan Doerr, Emily Edelman, Emily Gabitzsch, et al.
European Journal of Endocrinology|March 1, 2022
Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgeryFrederic Castinetti, Jean-Baptiste De Freminville, Carole Guerin, et al.
Pageof 59